Abstract
The role of melatonin in the regulation of human reproduction remains unclear. In the present study, we examined the influence of exogenous melatonin on pulsatile luteinizing hormone (LH), diurnal rhythm of testosterone, and endogenous melatonin profile in six healthy young adult males. To test the hypothesis that the effect of melatonin on LH or testosterone secretory patterns may be mediated through the benzodiazepine-(BNZ) γ-amino-butyric acid (GABA) receptor complex, a benzodiazepine receptor antagonist (Flumazenil) was administered. The study design comprised four 10-h (4:00 pm–2:00 am) testing periods. During each experimental period, subjects were given an oral dose of placebo, or 3 mg melatonin or 10 mg flumazenil, at 5:00 pm, in a randomized, double-blind, partially repeated Latin square design in the following combinations: placebo-placebo, placebo-melatonin, flumazenil-placebo, and flumazenil-melatonin. The following day, serum samples were obtained every 20 min between 4:00 pm and 2:00 am in a controlled light-dark environment for the determination of LH and melatonin levels. Serum testosterone concentrations were determined every 20 min between 7:00 and 8:00 am and 7:00 and 8:00 pm. A significant decrease in mean serum LH levels (p < 0.02) was observed in the melatonin-treated groups as compared with placebo-flumazenil groups. There was no change in LH pulse frequency, testosterone levels, or in melatonin onset time and amplitude. No additional effect of flumazenil on LH or testosterone levels was observed.
These data indicate that an evening melatonin administration decrease the next-day LH secretion in normal adult males without altering testosterone levels or the endogenous nocturnal melatonin secretory pattern. This effect of melatonin is not mediated through the benzodiazepine-GABA receptor complex.
Similar content being viewed by others
References
Aleem F. A., Weitzman E. D., and Weinberg U. (1984) Suppression of basal luteinizing hormone concentrations by melatonin in postmenopausal women. Fertil. Steril. 42, 923–925.
Anton-Tay F. (1974) Melatonin: effects on brain function. Adv. Biochem. Psychopharmacol. 11, 315–324.
Brzezinski A., Lynch J. H. J., Seibel H. M., et al. (1988) The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. Clin. Endocrinol. Metab. 66, 891–895.
Cagnacci A., Elliott J. A., and Yen S. S. C. (1991) Amplication of pulsatile LH secretion by exogenous melatonin in women. J. Clin. Endocrinol. Metab. 73, 210–212.
Cajochen C., Krauchi K., Mori D., et al. (1997) Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostatis. Am. J. Physiol. 272, R1189-R1196.
Deacon, S. and Arendt, J. (1995) Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans. Brain Res. 688, 77–85.
Dijk D. J., Roth C., Landal H. P., et al. (1995) Melatonin effect on daytime sleep in men: Suppression of EEC low-frequency activity and enhancement of spindle activity. Neurosci. Lett. 201, 13–16.
Garfinkel D., Laudon M., Nof D., and Zisapel M. (1995) Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346, 541–544.
Garfinkel D., Laudon M., and Zisapel N. (1997) Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch. Gerontol. Ger. 24, 223–231.
Green A. R., Nutt D. J., and Cowen P. J. (1982) Using RO 14-1788 to investigate the benzodiazepine receptor in vivo: Studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine RO 0-3663. Psychopharmacology 78, 293–295.
Luboshitzky R., Lavi S., Thuma I., and Lavie P. (1996a) Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J. Clin. Endocrinol. Metab. 81, 770–774.
Luboshitzky R., Wagner O., Lavi S., Herer P., and Lavie P. (1996b) Decreased nocturnal melatonin secretion in patients with Klinefelter’s syndrome. Clin. Endocrinol. 45, 749–754.
Luboshitzky R., Wagner O., Lavis S., Hrer P., and Lavie P. (1996c) Abnormal melatonin secretion in male patients with hypogonadism. J. Mol. Neurosci. 7, 91–98.
Nave R., Herer P., Haimov I., et al. (1996) Hypnotic and hypothermic effects of melatonin in daytime sleep in humans: lack of antagonism by flumazenil. Neurosci. Lett. 214, 123–126.
Nordlund J. J. and Lerner A. B. (1977) The effects of oral melatonin on skin color and on the release of pituitary hormones. J. Clin. Endocrinol. Metab. 45, 768–774.
Okatani Y. and Sagara Y. (1994) Amplification of nocturnal melatonin secretion in women with functional secondary amenorrhea: Relation to endogenous estrogen concentration. Clin. Endocrinol. 41, 763–770.
Reid K., Van Den Heuvel C., and Dawson D. (1996) Day-time melatonin administration: Effects on core temperature and sleep onset latency. J. Sleep Res. 5, 150–154.
Rosenstein R. E. and Cardinali D. P. (1990) Central gabaergic mechanisms as targets for melatonin activity in brain. Neurochem. Int. 17, 373–379.
Van Cauter E. (1988) Estimating false-positive and false-negative errors in analysis of hormonal pulsatility. Am. J. Physiol. 264, E786-E794.
Voordouw B. C. G., Euser R., Verdonk R. E. E., et al. (1992) Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhabit ovulation. J. Clin. Endocrinol. Metab. 74, 108–117.
Waldhauser F., Lieberman H. R., Lynch H. J., et al. (1987) A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology 46, 125–130.
Wayne N. L., Malpaux B., and Karsch F. (1988) How does melatonin code for day length in the ewe: Duration of nocturnal melatonin release or coincidence of melatonin with a light-entrained sensitive period. Biol. Reprod. 39, 66–75.
Weaver D. R., Stehle J. M., Stopa E. G., and Reppert S. N. (1993) Melatonin receptors in human hypothalmus and pituitary: Implications for circadian and reproductive responses to melatonin. J. Clin. Endocrinol. Metab. 71, 295–301.
Wright J., Aldhous M., Franey C., et al. (1986) The effects of exogenous melatonin on endocrine function in man. Clin. Endocrinol. 24, 375–382.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luboshitzky, R., Shen-Orr, Z., Shochat, T. et al. Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men. J Mol Neurosci 12, 75–80 (1999). https://doi.org/10.1385/JMN:12:1:75
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:12:1:75